citalopram has been researched along with Diffuse Myofascial Pain Syndrome in 6 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the selective serotonin reuptake inhibitor citalopram was studied in a randomized, double-blind, placebo-controlled, 4-month trial in patients with the fibromyalgia syndrome (FMS) who all fulfilled the American College of Rheumatology criteria." | 9.09 | Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study. ( Anderberg, UM; Marteinsdottir, I; von Knorring, L, 2000) |
| " In a double-blind, placebo-controlled study 22 patients with fibromyalgia were randomized to treatment with citalopram for 4 weeks at a dosage of 20 mg a day while 21 received placebo." | 6.68 | A randomized controlled trial of citalopram in the treatment of fibromyalgia. ( Danneskiold-Samstøe, B; Nørregaard, J; Volkmann, H, 1995) |
| "The effect of the selective serotonin reuptake inhibitor citalopram was studied in a randomized, double-blind, placebo-controlled, 4-month trial in patients with the fibromyalgia syndrome (FMS) who all fulfilled the American College of Rheumatology criteria." | 5.09 | Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study. ( Anderberg, UM; Marteinsdottir, I; von Knorring, L, 2000) |
| " The purposes of this case report are to describe how to identify serotonin syndrome in a patient who is taking citalopram (a selective serotonin reuptake inhibitor) on the basis of signs and symptoms and to promote the ability of physical therapists to recognize such signs and symptoms." | 3.74 | Misdiagnosis of serotonin syndrome as fibromyalgia and the role of physical therapists. ( Alnwick, GM, 2008) |
| " In a double-blind, placebo-controlled study 22 patients with fibromyalgia were randomized to treatment with citalopram for 4 weeks at a dosage of 20 mg a day while 21 received placebo." | 2.68 | A randomized controlled trial of citalopram in the treatment of fibromyalgia. ( Danneskiold-Samstøe, B; Nørregaard, J; Volkmann, H, 1995) |
| "Fibromyalgia is a clinically well-defined chronic condition with a biopsychosocial aetiology." | 2.52 | Selective serotonin reuptake inhibitors for fibromyalgia syndrome. ( Cantrell, SE; Häuser, W; Nishishinya, MB; Urrútia, G; Walitt, B, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walitt, B | 1 |
| Urrútia, G | 1 |
| Nishishinya, MB | 1 |
| Cantrell, SE | 1 |
| Häuser, W | 1 |
| Kayiran, S | 1 |
| Dursun, E | 1 |
| Dursun, N | 1 |
| Ermutlu, N | 1 |
| Karamürsel, S | 1 |
| Alnwick, GM | 1 |
| Nørregaard, J | 1 |
| Volkmann, H | 1 |
| Danneskiold-Samstøe, B | 1 |
| Baraczka, K | 1 |
| Jankó, Z | 1 |
| Vargha, K | 1 |
| Márkus, H | 1 |
| Anderberg, UM | 1 |
| Marteinsdottir, I | 1 |
| von Knorring, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Efficiency of a Therapeutic Education Program in Standardized Thermal Cure for Fibromyalgia Patients[NCT02406313] | 152 participants (Actual) | Interventional | 2015-03-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for citalopram and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Topics: Amitriptyline; Citalopram; Fibromyalgia; Fluoxetine; Humans; Melatonin; Musculoskeletal Pain; Paroxe | 2015 |
4 trials available for citalopram and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Neurofeedback intervention in fibromyalgia syndrome; a randomized, controlled, rater blind clinical trial.
Topics: Adolescent; Adult; Anxiety; Citalopram; Depression; Female; Fibromyalgia; Humans; Middle Aged; Neuro | 2010 |
A randomized controlled trial of citalopram in the treatment of fibromyalgia.
Topics: Adult; Antidepressive Agents; Citalopram; Double-Blind Method; Fibromyalgia; Humans; Middle Aged; Se | 1995 |
[Clinical experiences with the analgesic effects of citalopram].
Topics: Analgesics; Antidepressive Agents, Second-Generation; Chronic Disease; Citalopram; Fibromyalgia; Hum | 1997 |
Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study.
Topics: Acetaminophen; Activities of Daily Living; Adult; Analgesics, Non-Narcotic; Antidepressive Agents; C | 2000 |
1 other study available for citalopram and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Misdiagnosis of serotonin syndrome as fibromyalgia and the role of physical therapists.
Topics: Adult; Citalopram; Diagnostic Errors; Female; Fibromyalgia; Humans; Physical Therapy Specialty; Phys | 2008 |